Shatnawi A - Search Results

1

Identification of the inhibitor of growth protein 4 (ING4) as a potential target in prostate cancer therapy.

Shatnawi A, Malkaram SA, Fandy T, Tsouko E. Shatnawi A, et al. Mol Cell Biochem. 2020 Jan;464(1-2):153-167. doi: 10.1007/s11010-019-03657-x. Epub 2019 Nov 27. Mol Cell Biochem. 2020. PMID: 31773467

2

Molecular and genetic crosstalks between mTOR and ERRα are key determinants of rapamycin-induced nonalcoholic fatty liver.

Chaveroux C, Eichner LJ, Dufour CR, Shatnawi A, Khoutorsky A, Bourque G, Sonenberg N, Giguère V. Chaveroux C, et al. Among authors: shatnawi a. Cell Metab. 2013 Apr 2;17(4):586-98. doi: 10.1016/j.cmet.2013.03.003. Cell Metab. 2013. PMID: 23562079 Free article.

3

Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.

Carraway HE, Malkaram SA, Cen Y, Shatnawi A, Fan J, Ali HEA, Abd Elmageed ZY, Buttolph T, Denvir J, Primerano DA, Fandy TE. Carraway HE, et al. Among authors: shatnawi a. Sci Rep. 2020 Jun 25;10(1):10325. doi: 10.1038/s41598-020-67170-8. Sci Rep. 2020. PMID: 32587297 Free PMC article.

4

Author Correction: Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.

Carraway HE, Malkaram SA, Cen Y, Shatnawi A, Fan J, Ali HEA, Abd Elmageed ZY, Buttolph T, Denvir J, Primerano DA, Fandy TE. Carraway HE, et al. Among authors: shatnawi a. Sci Rep. 2020 Sep 22;10(1):15386. doi: 10.1038/s41598-020-70622-w. Sci Rep. 2020. PMID: 32968125 Free PMC article.

5

ING4 Expression Landscape and Association With Clinicopathologic Characteristics in Breast Cancer.

Shatnawi A, Ayoub NM, Alkhalifa AE. Shatnawi A, et al. Clin Breast Cancer. 2021 Aug;21(4):e319-e331. doi: 10.1016/j.clbc.2020.11.011. Epub 2020 Nov 19. Clin Breast Cancer. 2021. PMID: 33334698

6

Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancer.

Shatnawi A, Abu Rabe DI, Frigo DE. Shatnawi A, et al. Adv Cancer Res. 2021;152:225-262. doi: 10.1016/bs.acr.2021.05.004. Epub 2021 Jul 1. Adv Cancer Res. 2021. PMID: 34353439 Review.

7

Differential Histone Posttranslational Modifications Induced by DNA Hypomethylating Agents.

Malkaram SA, Shatnawi A, Fan J, Carraway H, Denvir J, Primerano DA, Abd Elmageed ZY, Fandy TE. Malkaram SA, et al. Among authors: shatnawi a. Cancer Control. 2022 Jan-Dec;29:10732748221074051. doi: 10.1177/10732748221074051. Cancer Control. 2022. PMID: 35067084 Free PMC article.

8

ELF3 is a repressor of androgen receptor action in prostate cancer cells.

Shatnawi A, Norris JD, Chaveroux C, Jasper JS, Sherk AB, McDonnell DP, Giguère V. Shatnawi A, et al. Oncogene. 2014 Feb 13;33(7):862-71. doi: 10.1038/onc.2013.15. Epub 2013 Feb 25. Oncogene. 2014. PMID: 23435425 Free PMC article.

9

Hormone depletion-insensitivity of prostate cancer cells is supported by the AR without binding to classical response elements.

Gonit M, Zhang J, Salazar Md, Cui H, Shatnawi A, Trumbly R, Ratnam M. Gonit M, et al. Among authors: shatnawi a. Mol Endocrinol. 2011 Apr;25(4):621-34. doi: 10.1210/me.2010-0409. Epub 2011 Feb 17. Mol Endocrinol. 2011. PMID: 21330406 Free PMC article.

10

Shatnawi A, Ayoub NM, Alkhalifa AE, Ibrahim DR. Shatnawi A, et al. Breast Cancer (Auckl). 2022 Mar 24;16:11782234221086713. doi: 10.1177/11782234221086713. eCollection 2022. Breast Cancer (Auckl). 2022. PMID: 35359609 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters